Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Terazosin hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Terazosin 2mg tablets
0205040V0AAABAB
|
Terazosin hydrochloride (Antihypertensive) | Terazosin hydrochloride | Cardiovascular System | 4,179 |
|
Terazosin 10mg tablets
0205040V0AAADAD
|
Terazosin hydrochloride (Antihypertensive) | Terazosin hydrochloride | Cardiovascular System | 4,029 |
|
Terazosin 5mg tablets
0205040V0AAACAC
|
Terazosin hydrochloride (Antihypertensive) | Terazosin hydrochloride | Cardiovascular System | 3,024 |
|
Hytrin 5mg tablets
0205040V0BBACAC
|
Hytrin | Terazosin hydrochloride | Cardiovascular System | 298 |
|
Hytrin 10mg tablets
0205040V0BBADAD
|
Hytrin | Terazosin hydrochloride | Cardiovascular System | 107 |
|
Hytrin 2mg tablets
0205040V0BBABAB
|
Hytrin | Terazosin hydrochloride | Cardiovascular System | 77 |
|
Terazosin 2mg tablets and Terazosin 1mg tablets
0205040V0AAAAAA
|
Terazosin hydrochloride (Antihypertensive) | Terazosin hydrochloride | Cardiovascular System | 23 |
|
Hytrin tablets starter pack
0205040V0BBAEAA
|
Hytrin | Terazosin hydrochloride | Cardiovascular System | 4 |
|
Hytrin BPH tablets starter pack
0704010T0BBAEAE
|
Hytrin BPH | Terazosin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2 |
|
Generic Hytrin BPH tablets starter pack
0704010T0AAAEAE
|
Terazosin hydrochloride (Urinary retention) | Terazosin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1 |
|
Benph 2mg tablets
0205040V0BCAAAB
|
Benph | Terazosin hydrochloride | Cardiovascular System | No data available |
|
Benph 5mg tablets
0205040V0BCABAC
|
Benph | Terazosin hydrochloride | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.